NAMSA Expands Capabilities with Acquisition of WuXi AppTec's US Medical Device Testing Facilities
In a strategic move to enhance its medical device testing capabilities, NAMSA has acquired WuXi AppTec's US-based facilities. The companies are committed to a seamless transition, ensuring uninterrupted service for employees and customers. This acquisition strengthens NAMSA's position in the medical device testing industry, providing comprehensive testing solutions for medical device manufacturers. With a focus on quality and regulatory compliance, NAMSA is well-positioned to support the growth of the medical device industry. By leveraging its expanded capabilities, NAMSA aims to deliver exceptional service and support to its customers, driving innovation in the medical device sector. Key areas of focus include regulatory testing and medical device development.
